Immix Biopharma Inc
(IMMX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 4,703 | 5,590 | 5,376 | 4,524 | 3,721 |
| Operating Income | -4,703 | -5,590 | -5,376 | -4,524 | -3,721 |
| Other Income | 307 | 268 | 229 | 187 | 129 |
| Pre-tax Income | -4,396 | -5,322 | -5,147 | -4,337 | -3,592 |
| Income Tax | 10 | 9 | 8 | 7 | 6 |
| Net Income Continuous | -4,406 | -5,331 | -5,155 | -4,344 | -3,598 |
| Minority Interests | -13 | -72 | -66 | -63 | -22 |
| Net Income | $-4,393 | $-5,259 | $-5,090 | $-4,281 | $-3,576 |
| EPS Basic Total Ops | -0.15 | -0.22 | -0.24 | -0.23 | -0.24 |
| EPS Basic Continuous Ops | -0.15 | -0.23 | -0.25 | -0.23 | -0.24 |
| EPS Diluted Total Ops | -0.15 | -0.22 | -0.24 | -0.23 | -0.24 |
| EPS Diluted Continuous Ops | -0.15 | -0.23 | -0.25 | -0.23 | -0.24 |
| EPS Diluted Before Non-Recurring Items | -0.15 | -0.22 | -0.24 | N/A | N/A |
| EBITDA(a) | $-4,678 | $-5,566 | $-5,373 | $-4,522 | $-3,720 |